Filter
1771
Filtered Results: 1771
Text search:
intellectual
property
Featured
Recommendations
209
New Publications
390
Language
Document type
No document type
705
Studies & Reports
365
Guidelines
318
Manuals
183
Strategic & Response Plan
110
Training Material
46
Fact sheets
29
Situation Updates
7
Resource Platforms
5
Infographics
3
Countries / Regions
Global
138
India
35
Africa
28
Western and Central Europe
27
Kenya
26
Ukraine
26
South–East Asia Region
26
Uganda
24
South Africa
22
Nepal
20
Ethiopia
20
Ghana
17
Nigeria
15
Eastern Europe and Central Asia
15
Asia
14
West and Central Africa
14
East and Southern Africa
14
Myanmar / Burma
13
Sierra Leone
12
Malawi
12
Bangladesh
12
Zambia
12
Rwanda
11
Syria
11
Middle East and North Africa
11
Indonesia
11
Liberia
11
Cambodia
10
Tanzania
9
Yemen
8
Lesotho
7
Afghanistan
7
Western Pacific Region
7
Eastern Europe
7
South Sudan
7
Latin America and the Carribbean
6
Cameroon
5
Zimbabwe
5
Philippines
5
Guinea
5
Mozambique
5
Congo, Democratic Republic of
5
Somalia
5
Pakistan
5
Thailand
4
Haiti
4
Germany
4
Vietnam
4
Russia
4
Sudan
4
North Macedonia
3
Tajikistan
3
Kazakhstan
3
Iran
3
Laos
3
Burkina Faso
3
Jordan
3
Lebanon
3
Colombia
2
China
2
Chile
2
Kyrgyzstan
2
Peru
2
Venezuela
2
Lithuania
2
Saudi Arabia
2
Côte d’Ivoire / Ivory Coast
2
Djibouti
2
Palestine
2
Georgia
2
Angola
2
Botswana
2
Iraq
2
Ecuador
2
Timor Leste/ East Timor
1
Mexico
1
Serbia
1
Turkey
1
Benin
1
Albania
1
Canada
1
Senegal
1
Estonia
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
USA
1
Paraguay
1
Japan
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Sri Lanka
1
Namibia
1
Egypt
1
Greece
1
Central African Republic
1
Mali
1
Chad
1
Libya
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
374
Clinical Guidelines
215
Public Health
159
Women & Child Health
131
Key Resources
105
Capacity Building
55
Pharmacy & Technologies
41
Toolboxes
Mental Health
184
Disability
150
HIV
140
COVID-19
136
TB
88
Planetary Health
82
Caregiver
80
NTDs
64
Rapid Response
62
AMR
62
Global Health Education
54
Pharmacy
42
NCDs
42
Conflict
42
Health Financing Toolbox
23
Refugee
20
Ebola
17
Social Ethics
13
Natural Hazards
11
Specific Hazards
9
Polio
5
Cholera
3
Zika
3
VADEMECUM | This Vademecum is intended to provide a benchmark for aid workers—whether working in the field or at a strategic level—in particular concerning the formulation and implementation of programmes of prevention or response to humanitarian crises. It is not solely a theoretical document b...
The target audience of this document (and the associated online companion tool) includes WHO country offices
in Member States of the African Region; Member States’ ministries of health and their public health emergency
operation centres; relevant external assessment teams; and partners looking...
The World Health Organization provides regional and national strategies and operational plans that aim to support countries in work to achieve measles control and elimination. These are guided by high level frameworks including the Immunization Agenda 2030 and the Measles and Rubella Strategic Frame...
Pneumonia and diarrhoea account for 23% of under-five mortality and were responsible for an estimated 1.17 million deaths in children under five globally. Furthermore, pneumonia and diarrhoea were responsible for 18% of mortality in children 5–9 years of age, resulting in an estimated 86 000 preve...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
The development of this target product profile (TPP) was led by the WHO Department of Control of Neglected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG) was form...
Tis first edition describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them. These include albendazole for lymphatic filariasis and soil-transmitted helminthiases; azithromycin for trachoma and yaws; diethylca...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
The meeting was held from 26 to 27 March 2018 to review and discuss the following topics:
Advances and challenges in the use of fTLC, and new approaches to detecting mycolactone using monoclonal antibodies (mAbs).
The status of development of rapid diagnostic tests (RDTs) targeting the MUL...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are needed in some cases to ensure full recovery.
The targ...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
This document provides the specifications for major pesticide application equipment used for control of vectors of diseases. The specification guidelines contained herein are intended to assist national authorities and other public health users in selecting equipment of assured quality for applicati...
Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u...
This document outlines the evaluation process that WHO undertakes to assess novel tools and strategies targeted at VBDs. Its aim is to articulate the linkage between the generation of evidence that demonstrates public health impact of novel interventions, and the development of policy recommendation...
The Global vector control response 2017–2030 (GVCR) provides a new strategy to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integrated action across sectors and diseases.
In May 2017, the World Health Assembly adopted resolutio...
In May 2017, the World Health Assembly adopted resolutio...
